Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia

被引:3
|
作者
Milionis, HJ
Bairaktari, ET
Liberopoulos, EN
Elisaf, MS
机构
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 02期
关键词
D O I
10.1016/S0002-9149(01)01660-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:203 / 203
页数:1
相关论文
共 50 条
  • [1] Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia
    Bairaktari, ET
    Tzallas, CS
    Tsimihodimos, VK
    Liberopoulos, EN
    Miltiadous, GA
    Elisaf, MS
    JOURNAL OF CARDIOVASCULAR RISK, 1999, 6 (02): : 113 - 116
  • [2] Effects of atorvastatin vs. fenofibrate on ghrelin levels in type 2 diabetic patients with mixed hyperlipoproteinemia
    Otto, C
    Otto, B
    Frost, R
    Geiss, H
    Parhofer, K
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 141 - 141
  • [3] Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia
    Steinmetz, A
    Schwartz, T
    Hehnke, U
    Kaffarnik, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (04) : 563 - 570
  • [4] Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels:: a 12-week randomized trial
    Després, JP
    Lemieux, I
    Salomon, H
    Delaval, D
    JOURNAL OF INTERNAL MEDICINE, 2002, 251 (06) : 490 - 499
  • [5] Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemia
    Miltiadous, G
    Bairaktari, E
    Tzallas, C
    Tsimihodimos, V
    Liberopoulos, E
    Millionis, H
    Rizos, E
    Elisaf, M
    ATHEROSCLEROSIS, 1999, 144 : 37 - 37
  • [6] Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia
    D.N. Kiortsis
    H. Millionis
    E. Bairaktari
    M.S. Elisaf
    European Journal of Clinical Pharmacology, 2000, 56 : 631 - 635
  • [7] Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia
    Kiortsis, DN
    Millionis, H
    Bairaktari, E
    Elisaf, MS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (9-10) : 631 - 635
  • [8] Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia
    Athyros, VG
    Papageorgiou, AA
    Athyrou, VV
    Demitriadis, DS
    Kontopoulos, AG
    DIABETES CARE, 2002, 25 (07) : 1198 - 1202
  • [9] Effects of Atorvastatin versus Fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia
    Frost, RJA
    Otto, C
    Geiss, HC
    Schwandt, P
    Parhofer, KG
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (01): : 44 - 48
  • [10] Effects of atorvastatin on remnant lipoprotein metabolism in type III hyperlipoproteinemia - Comparison with fenofibrate
    Ishigami, M
    Yamashita, S
    Sakai, N
    Hirano, K
    Hiraoka, H
    Nakamura, T
    Matsuzawa, Y
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 161 - 161